These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3711314

  • 1. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B, Morel E, Bach JF.
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity.
    Vernet-der Garabedian B, Eymard B, Bach JF, Morel E.
    J Neuroimmunol; 1989 Jan; 21(1):41-7. PubMed ID: 2908881
    [Abstract] [Full Text] [Related]

  • 6. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H, Hayashi K, Ohta K, Itoh N, Nishitani H, Ohta M.
    Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390
    [Abstract] [Full Text] [Related]

  • 7. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL, Ringel SP, Cook JD, Engel WK, Eldefrawi ME, McFarlin DE.
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B, Harrison R, Lunt GG, Morris H, Savage-Marengo T, Stephenson FA.
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
    Besinger UA, Toyka KV, Hömberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A.
    Neurology; 1983 Oct; 33(10):1316-21. PubMed ID: 6684226
    [Abstract] [Full Text] [Related]

  • 14. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
    Vincent A, Newsom-Davis J.
    Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Lu CZ, Link H, Mo XA, Xiao BG, Zhang YL, Qin Z.
    J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731
    [Abstract] [Full Text] [Related]

  • 17. Future therapeutic strategies in autoimmune myasthenia gravis.
    Psaridi-Linardaki L, Mamalaki A, Tzartos SJ.
    Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
    [Abstract] [Full Text] [Related]

  • 18. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
    Aurangzeb S, Tariq M, Irshad M, Badshah M, Khan RS.
    J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H, Kokla A, Trakas N, Tzartos SJ.
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.